AIDS in Developing Countries
AIDS in Developing Countries | U.S. Pharmaceutical Companies and the U.S. Government Have Blocked the Availability of AIDS Drugs in Developing Countries
Robert Weissman is editor of Multinational Monitor magazine and codirector of Essential Action, a corporate accountability group. He also is coauthor of Corporate Predators: The Hunt for Megaprofits and the Attack on Democracy.
Summary: The United States government and U.S. pharmaceutical companies have actively opposed efforts by developing countries to make life-saving AIDS drugs more affordable and available in their countries. The efforts of these developing countries involve compulsory licensing and parallel importing, two ways of making AIDS drugs...
[The entire page is 2615 words long]
Navigate
- Introduction
-
Table of Contents
- AIDS in Developing Countries: An Overview
- AIDS Is a Threat to Human Development and Security in Developing Countries
- The United States Should Provide Financial Assistance to Developing Countries to Combat AIDS
- The AIDS Epidemic Demands Action from the International Community
- The AIDS Epidemic Demands Action from Developing Countries
- African Nations Are Committed to Fighting the AIDS Epidemic
- The Chinese Government Is Hampering the Fight Against the AIDS Epidemic
- A Deadly Passage to India
- U.S. Pharmaceutical Companies and the U.S. Government Have Blocked the Availability of AIDS Drugs in Developing Countries
- U.S. Pharmaceutical Companies Have Helped Make AIDS Drugs Available in Developing Countries
- Rich and Poor Nations Should Collaborate in the Development of an AIDS Vaccine
- The Collaboration of Rich and Poor Nations in AIDS Research Creates Ethical Problems
- The Development of an AIDS Vaccine Is Not a “Magic Bullet” Solution
- Reducing Poverty Can Reduce AIDS in Developing Countries
- Developing Countries Need to Reduce Risky Behavior to Prevent AIDS
- Organizations to Contact
- Bibliography
- Copyright
Tell a friend about AIDS in Developing Countries at eNotes.
